MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells

Lung Cancer

Volumn 83, Issue 2, 2014, Pages 154-162

  Ho, Chai San ^a   Yap, Seow Hui ^a   Phuah, Neoh Hun ^a   In, Lionel L A ^a   Hasima, Noor ^a,b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Angiogenesis; Invasion; Metastasis; MicroRNA; Migration; Non small cell lung cancer

Indexed keywords

INTEGRIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANGIOGENESIS ASSAY; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MARKER GENE; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WOUND HEALING;

ANGIOGENESIS; INVASION; METASTASIS; MICRORNA; MIGRATION; NON-SMALL CELL LUNG CANCER;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; COMPUTER SIMULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 2; GENE EXPRESSION PROFILING; HUMANS; INTEGRINS; LUNG NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; SOFTWARE; SRC-FAMILY KINASES; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 84892873879     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.11.024     Document Type: Article

References (59)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Xia M., Hu M. The role of microRNA in tumor invasion and metastasis. J Cancer Mol 2010, 5:33-39.
3. Berghmans T., Paesmans M., Sculier J.P. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol 2011, 3:127-138.
4. Ma M., Shen J., Jiang L., Han B., Bai H., Ji H., et al. Prognostic factors in patients with stage IV non-small cell lung cancer. Chin-German J Clin Oncol 2006, 5:319-323.
5. Friedl P., Brocker E.B. The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci 2000, 57:41-64.
6. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2:91-100.
7. Nobes C.D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81:53-62.
8. Jing Y., Han Z., Zhang S., Liu Y., Wei L. Epithelial-mesenchyman transition in tumor microenvironment. Cell Biosci 2011, 1:29.
9. Wu Q.A., Li H.L., Lu J.F., Ge Q.Y., Lu Z.H. Aberrant microRNA expression in the development of breast carcinoma. Chin Sci Bull 2010, 55:3517-3526.
10. Du L., Pertsemlidis A. microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Rev 2010, 29:109-122.
11. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
12. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
13. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210.
14. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumour suppressor genes in invasion and metastasis. Cell Res 2008, 18:350-359.
15. Crawford M., Brawner E., Batte K., Yu L., Hunter M.G., Otterson G.A., et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008, 373:607-612.
16. Spremulli E.N., Dexter D.L. Human tumor cell heterogeneity and metastasis. J Clin Oncol 1983, 1:496-509.
17. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
18. Geback T., Schulz M.M., Koumoutsakos P., Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009, 46:265-274.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ddCT method. Methods 2001, 25:402-408.
20. Papadopoulos G.L., Alexiou P., Maragkakis M., Reczko M., Hatzigeorgiou A.G. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25:1991-1993.
21. Maragkakis M., Vergoulis T., Alexiou P., Reczko M., Plomaritou K., Gousis M., et al. DIANA-microT web server upgrade supports fly and worm miRNA target prediction and bibliographic miRNA to disease association. Nucleic Acids Res 2011, 39:W145-W148.
22. Koparal A.T., Zeytinoglu M. Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549. Cytotechnology 2003, 43:149-154.
23. Leivonen S.K., Kahari V.M. Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 2007, 121:2119-2124.
24. Xu C.C., Wu L.M., Sun W., Zhang N., Chen W.S., Fu X.N. Effects of TGF-b signalling blockade on human A549 lung adenocarcinoma cell lines. Mol Med Rep 2011, 4:1007-1015.
25. Tian F., Byfield S.D., Parks W.T., Yoo S., Felici A., Tang B.W., et al. Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 2003, 63:8284-8292.
26. Zhang S.P., Fei T., Zhang L.X., Zhang R., Chen F., Ning Y.H., et al. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 2007, 27:4488-4499.
27. Ebisawa T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., et al. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 2001, 276:12477-12480.
28. Azuma H., Ehata S., Miyazaki H., Watabe T., Maruyama O., Imamura T., et al. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J Natl Cancer Inst 2005, 97:1734-1746.
29. Javelaud D., Delmas V., Moller M., Sextius P., Andre J., Menashi S., et al. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 2005, 24:7624-7629.
30. Lee E.H., Chari R., Lam A., Ng R.T., Yee J., English J., et al. Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma. Clin Med Oncol 2008, 2008:169-179.
31. Wang Y.Q. Wnt/planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 2009, 8:2103-2109.
32. Cirone P., Lin S., Griesbach H.L., Zhang Y., Slusarski D.C., Crews C.M. A role for planar cell polarity signaling in angiogenesis. Angiogenesis 2008, 11:347-360.
33. Kurayoshi M., Oue N., Yamamoto H., Kishida M., Inoue A., Asahara T., et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006, 66:10439-10448.
34. Huang C.L., Liu D., Nakano J., Ishikawa S., Kontani K., Yokomise H., et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor - an expression in non-small-cell lung cancer. J Clin Oncol 2005, 23:8765-8773.
35. Sato A., Khadka D.K., Liu W., Bharti R., Runnels L.W., Dawid I.B., et al. Profilin is an effector for Daam1 in non-canonical Wnt signaling and is required for vertebrate gastrulation. Development 2006, 133:4219-4231.
36. Strutt D.I., Weber U., Mlodzik M. The role of RhoA in tissue polarity and frizzled signalling. Nature 1997, 387:292-295.
37. Habas R., Dawid I.B., He X. Coactivation of Rac and Rho by Wnt/frizzled signaling is required for vertebrate gastrulation. Genes Dev 2003, 17:295-309.
38. Bhat R.A., Stauffer B., Komm B.S., Bodine P.V. Structure-function analysis of secreted frizzled-related protein-1 for its Wnt antagonist function. J Cell Biochem 2007, 102:1519-1528.
39. ten Klooster J.P., Jaffer Z.M., Chernoff J., Hordijk P.L. Targeting and activation of Rac1 are mediated by the exchange factor beta-Pix. J Cell Biol 2006, 172:759-769.
40. Bernard O. Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 2007, 39:1071-1076.
41. Kumar R., Gururaj A.E., Barnes C.J. p21-Activated kinases in cancer. Nat Rev Cancer 2006, 6:459-471.
42. Kurisu S., Suetsugu S., Yamazaki D., Yamaguchi H., Takenawa T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 2005, 24:1309-1319.
43. Sossey-Alaoui K., Safina A., Li X., Vaughan M.M., Hicks D.G., Bakin A.V., et al. Down-regulation of WAVE3, a metastatis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 2007, 170:2112-2121.
44. Eliceiri B.P. Integrin and growth factor receptor crosstalk. Circ Res 2001, 89:1104-1110.
45. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994, 372:786-791.
46. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826.
47. Meng X.N., Jin Y., Yu Y., Bai J., Liu G.Y., Zhu J., et al. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Brit J Cancer 2009, 101:327-334.
48. Mavria G., Vercoulen Y., Maggie Y., Paterson H., Karasarides M., Marais R., et al. ERK-MAPK signaling opposes Rho kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 2006, 9:33-34.
49. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997, 137:481-492.
50. Schlaepfer D.D., Jones K.C., Hunter T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2 mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol 1998, 18:2571-2585.
51. Lei L., Huang Y., Gong W. Inhibition of hsa-miR-92b suppresses non-small cell lung cancer cells growth and motility by targeting RECK. Mol Cell Biochem 2013, 10.1007/s11010-013-1882-5.
52. Qian J., Lin J., Qian W., Ma J.-C., Qian S.-X., Li Y., et al. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia. Leuk Res 2013, 37.
53. Fei B., Wu H. miR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncol Res Featur Preclin Clin Cancer Ther 2012, 20.
54. Ferrarelli L.K. Cancer deciphering he signatures of bone metastases. Sci Signal 2013, 6.
55. Daniel L.Y., Deng Z., Wang C.-H., Burton Y.B. miRNA-378 promotes cell survival tumor growth and angiogenesis by targeting SuFu and Fus-1 expression. PNAS 2007, 104.
56. Skrzpek K., Tertil M., Golda S., Ciesla M., Weglarczyk K., Colet G., et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung adenocarcinoma growth vascularization and metastasis. Antioxid Redox Signal 2013.
57. Chen L.T., Xu S.D., Xu H., Zhang J.F., Ning J.F., Wang S.F. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Med Oncol 2012, 29:1673-1680.
58. Xiong F., Wu C., Chang J., Yu D., Xu B., Yuan P., et al. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 2011, 71:5175-5181.
59. Liu F., Xiong Y., Zhao Y., Tao L., Zhang Z., Zhang H., et al. Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. Diagn Pathol 2013, 8.